The ongoing European Association for the Study of the Liver 2024 congress in Milan opened yesterday with several presentations on cell plasticity and its role in liver function and regeneration in chronic liver disease situations.

Genome sequencing initiated to investigate how chronic liver disease leads on to hepatocellular carcinoma has instead uncovered mutations that impact fat metabolism and reduce the sensitivity of hepatocytes to insulin.